Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The master cytokine TGF-β mediates tissue fibrosis associated with inflammation and tissue injury. TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins. Canonical TGF-β signaling mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression. However, the importance of TGF-β-Smad2/3 signaling in fibroblast-mediated cardiac fibrosis has not been directly evaluated in vivo. Here, we examined pressure overload-induced cardiac fibrosis in fibroblast- and myofibroblast-specific inducible Cre-expressing mouse lines with selective deletion of the TGF-β receptors Tgfbr1/2, Smad2, or Smad3. Fibroblast-specific deletion of Tgfbr1/2 or Smad3, but not Smad2, markedly reduced the pressure overload-induced fibrotic response as well as fibrosis mediated by a heart-specific, latency-resistant TGF-β mutant transgene. Interestingly, cardiac fibroblast-specific deletion of Tgfbr1/2, but not Smad2/3, attenuated the cardiac hypertrophic response to pressure overload stimulation. Mechanistically, loss of Smad2/3 from tissue-resident fibroblasts attenuated injury-induced cellular expansion within the heart and the expression of fibrosis-mediating genes. Deletion of Smad2/3 or Tgfbr1/2 from cardiac fibroblasts similarly inhibited the gene program for fibrosis and extracellular matrix remodeling, although deletion of Tgfbr1/2 uniquely altered expression of an array of regulatory genes involved in cardiomyocyte homeostasis and disease compensation. These findings implicate TGF-β-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, cultured human primary cardiac and dermal fibroblasts and immortalized cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ (refs. 19,39,40), IL-1β (ref. 41)) conditions.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“TGF-β1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [85]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, primary human cardiac fibroblasts, primary human dermal fibroblasts, and immortalized human cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ 20,33,34 , IL-1 β 35 ) conditions.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While numerous studies have implicated a role for TGFβ signaling in maladaptive cardiac remodeling and scar formation in HF 20,33”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · cited 1×
“Heart failure is an increasingly prevalent disease characterized by reduced cardiac output resulting from a progressive loss of cardiomyocytes, ventricular chamber remodeling, and accumulation of interstitial fibrosis (1).”
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · cited 1×
“Global TGF-β activity is upregulated in diseased hearts, where one of its primary actions is directed at the resident fibroblasts to alter the fibrotic response and ventricular remodeling (47, 48).”
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425 · cited 1×
“The ratio of these measures ( E/e ′ ) was used as an indicator of diastolic function (60).”
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 6×
“Hence, here we used mice in which the Postn genetic locus was targeted with a tamoxifen-inducible MerCreMer (MCM) cDNA (29), and these mice were crossed with Smad2 fl/fl , Smad3 fl/fl , Smad2/3 fl/fl , and Tgfbr1/2 fl/fl targeted mice (Figure 2A).”
InfluentialSelf-citation
Cited by
Items 401–500 of 925
Fan, W., Qu, Y., Yuan, X., Shi, H., & Liu, G. (2024) · Phytotherapy Research · doi:10.1002/ptr.8373 · Cited by 23
“…receptors on the cell membrane, inducing various biological functions including immune responses, inflammation, angiogenesis, cell growth, and apoptosis (Syed 2016), and TGF-β1 is one of the important factors that influence the activation of fibroblasts into myofibroblasts (Khalil et al. 2017).”
Zhang, S., Elbs‐Glatz, Y., Tao, S., Schmitt, S., Li, Z., Rottmar, M., Maniura‐Weber, K., & Ren, Q. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02179-y · Cited by 23
“Among the differentiation processes, Smad2 and 3 genes are the most central genes of the TGF-β/Smad signaling pathway to guide the differentiation from fibroblasts to myofibroblasts [47].”
Mitochondrial Dysfunction-Associated Arrhythmogenic Substrates in Diabetes Mellitus
Song, J., Yang, R., Yang, J., & Zhou, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01670 · Cited by 19
“Activated TGF-β1 binds to its membrane receptors phosphorylates transcription factors SMAD2/3, which activates the canonical (SMAD-dependent) fibrogenic pathway (Verrecchia and Mauviel, 2002; Khalil et al., 2017), leading to myofibroblast differentiation and fibrosis (Lijnen et al., 2003).”
BackgroundThe heart under pressure: immune cells in fibrotic remodeling
Theall, B. P., & Alcaide, P. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100484 · Cited by 21
Zheng, W., Chen, A., Yang, H., & Hong, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8924 · Cited by 18
“Similar to other SMADs, SMAD2 serves a role in the transmission of extracellular signals from TGF-β ligands into the cell nucleus and mediates cell proliferation, apoptosis and differentiation (45).”
BackgroundPeriplocymarin protects against myocardial fibrosis induced by β-adrenergic activation in mice
Yun, W., Lei, Q., Yuan, R., & Xu, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111562 · Cited by 18
Methatham, T., Nagai, R., & Aizawa, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084302 · Cited by 19
“In a pressure overload model, mice with fibroblast-specific deletion of the type I receptor (TβRI) or the type II receptor (TβRII) showed less cardiac fibrosis, indicating that activation of TGF-β signaling is required for the process of fibrosis [92].”
BackgroundInfluentialHippo-Yap signaling in cardiac and fibrotic remodeling
Re, D. P. D. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100492 · Cited by 22
Isolation of Adult Mouse Cardiac Fibroblasts
Almazloum, A., & Khalil, H. (2023) · Current Protocols · doi:10.1002/cpz1.840 · Cited by 18
“We previously utilized this protocol to isolate primary fibroblasts for RNA-sequencing (RNA-Seq) profiling (Khalil et al., 2017).”
MethodSelf-citationZeng, K.-F., Wang, H., Deng, B., Chen, T.-F., Chen, J.-B., Ding, W.-J., Chen, S., Xie, J.-D., Lu, S.-M., Chen, G.-H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155118 · Cited by 18
Chen, Y.-J., Huang, S., Tai, M., Chen, J., Lee, A., Huang, R., & Liang, C. (2019) · Pharmacological Reports · doi:10.1007/s43440-019-00026-9 · Cited by 18
Shao, X., Zhang, X., Yang, L., Zhang, R., Zhu, R., & Feng, R. (2020) · Epigenetics · doi:10.1080/15592294.2020.1827721 · Cited by 18
“Extensive studies have demonstrated that many regulators are involved in the cardiac remodelling through TGF-β signalling pathway [8,9,41].”
BackgroundLi, X., Wang, X., Wang, Y., Liang, Q., Li, Y., Chen, Y.-W., & Ming, H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114858 · Cited by 21
Hiromura, M., Mori, Y., Terasaki, M., Kushima, H., Saito, T., Osaka, N., Yashima, H., Ohara, M., Fukui, T., Matsui, T., et al. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/1479164121999034 · Cited by 17
Zhang, M., Lu, P., Zhao, F., Sun, X., Ma, W., Tang, J., Zhang, C., Ji, H., & Wang, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115751 · Cited by 18
Heinzmann, D., Fuß, S., von Ungern‐Sternberg, S. N. I., Schreieck, J., Gawaz, M., Gramlich, M., & Seizer, P. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492873 · Cited by 17
Yang, H., Xu, G., Zhang, C., Sun, J., Zhang, Y., Song, J., Li, Y., Liu, Y., & Li, A. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4410 · Cited by 27
“Numerous studies have demonstrated that the Smad‐dependent pathway contributes to myocardial fibrosis in the TGF-β-induced signaling pathway (10,12,35,36).”
BackgroundWang, T., Duan, Y., Fu, Q., Liu, T., Jin-cheng, Y., Sui, Z., Huang, L. F., & Wen, G. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0384 · Cited by 17
Liu, S., Huang, X., Liu, Y., Song, D., & Xiao, Y. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03741-7 · Cited by 18
Tschöpe, C., & Díez, J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy307 · Cited by 17
TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac Fibrosis
Groß, S., & Thum, T. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.013 · Cited by 18
“As TGF-b is the major regulator of the profibrotic response, not only in the heart, these findings are contradictory (10).”
BackgroundRole of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation
Ghiroldi, A., Piccoli, M., Creo, P., Cirillo, F., Rota, P., D’Imperio, S., Ciconte, G., Monasky, M. M., Micaglio, E., Garatti, A., et al. (2020) · Biochemical Journal · doi:10.1042/bcj20200360 · Cited by 16
Papke, D. J., & Hornick, J. L. (2021) · Histopathology · doi:10.1111/his.14450 · Cited by 16
“SMAD3 has been shown to promote expression of fibrillar collagen genes, including COL1A1 and COL6A3 among others, and inhibition of SMAD3 has been shown to reduce cardiac fibrosis.(29,30) Interestingly, A”
BackgroundAdriamycin induces cardiac fibrosis in mice via PRMT5-mediated cardiac fibroblast activation
Dong, X., Yuan, B.-H., Yu, S.-Z., Liu, H., Pan, X., Sun, J. T., & Pan, L. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00963-x · Cited by 16
“The fibrotic process is driven primarily by local myocardial increase in TGF-β1 [25].”
BackgroundAlghamdi, A., Alyami, A., Althaqafi, R. M. M., Alzeyadi, A., Alrubaei, F. S., Alyami, A. A., Singer, M. S., Saati, A. A., Alotaibi, W. T., & Alsharif, M. O. (2023) · Cureus · doi:10.7759/cureus.36070 · Cited by 16
“Fibroblast activation can be enhanced by the platelet-derived growth factor (PDGF) in the context of FS development [33], while TGF-β- Smad2/3 signaling in cardiac fibroblasts was further demonstrated to be a main pathway of the fibrotic response [46].”
BackgroundWerner, F., Santos, E. P., Michel, K., Schrader, H., Völker, K., Potapenko, T., Krebes, L., Abeßer, M., Möllmann, D., Schlattjan, M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.160416 · Cited by 16
“Concomitant attenuation of pathological cardiac fibrosis and myocyte hypertrophy was observed in mice with fibroblast-restricted deletion of profibrotic signaling molecules, such as TGF-β receptors 1 and 2, Hsp47, or G protein–coupled receptor kinase 5 (GRK5) (21–23).”
Angiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism
Li, J., Jia, J., Dong, L., Hu, Z., Huang, X., Wang, H., Wang, L., Yang, S., & Lan, H. Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.017 · Cited by 16
Young, O. N., Bourke, J. E., & Widdop, R. E. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115839 · Cited by 17
Mst1/Hippo signaling pathway drives isoproterenol-induced inflammatory heart remodeling
He, X., Huang, S., Yu, C., Chen, Y., Zhu, H., Li, J., & Chen, S. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.95850 · Cited by 16
“This fibrotic response is mediated by TGF-β, a pro-fibrotic cytokine upregulated during inflammation [32].”
BackgroundTran, K.-V. (2019) · Journal of Clinical and Translational Research · doi:10.18053/jctres.05.201901.003 · Cited by 16
“Cardiac cell death subsequently leads to tissue fibrosis, which is in part coordinated through the TGF-β signalizing pathway [41,42].”
BackgroundGenetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype
Kant, T. A., Newe, M., Winter, L., Hoffmann, M., Kämmerer, S., Klapproth, E., Künzel, K., Kühnel, M., Neubert, L., El‐Armouche, A., et al. (2021) · Cells · doi:10.3390/cells10030617 · Cited by 17
“Mechanistically, the phosphorylation of SMAD2/3 is considered a crucial step in fibroblast activation and fibrosis formation [33,34].”
BackgroundYadav, S., Srivastava, S., & Singh, G. (2022) · Environmental Toxicology · doi:10.1002/tox.23456 · Cited by 18
Novel Insights into the Cardioprotective Effects of Calcitriol in Myocardial Infarction
Yang, S., Wang, C., Ruan, C.-S., Chen, M., Cao, R., Sheng, L., Chang, N., Xu, T., Zhao, P.-W., Liu, X., et al. (2022) · Cells · doi:10.3390/cells11101676 · Cited by 17
“After LAD ligation, all mice were randomly divided into six groups and received the following drug administration via oral gavage once daily as described in previous studies [10,11]: (1) Sham group, 10 mL/kg/day corn oil (n = 9); (2) MI group, 10 mL/kg/day corn oil (n = 12); (3) Low dose calcitriol-treated group, 0.”
MethodGe, C., Zhao, Y., Liang, Y., & He, Y. (2022) · Disease Markers · doi:10.1155/2022/2466150 · Cited by 17
Meng, J., Ma, A., Zhang, S., Lin, D., Lin, S., Li, M., Zhou, H. Y., & Yang, B. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100152 · Cited by 16
Jiang, F., Zhang, W., Lu, H., Tan, M., Zeng, Z., Song, Y., Xiao, K., & Lin, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886860 · Cited by 18
“reported that TGFBR1 participates in tissue fibrosis primarily via the TGFβ-/Smad signaling pathway (Khalil et al., 2017).”
BackgroundTian, Y., Tsujisaka, Y., Li, V. Y., Tani, K., Lucena-Cacace, A., & Yoshida, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1001453 · Cited by 18
“TGF-β1 is one of the most potent pathological activators of COL1A1 fostering ECM depositions (Khalil et al., 2017), and this effect is finely controlled through interleukin-11 (IL-11)”
BackgroundCalcium-Signalling in Human Glaucoma Lamina Cribrosa Myofibroblasts
Irnaten, M., & O'Brien, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021287 · Cited by 17
Jahan, F., Landry, N. M., Rattan, S. G., Dixon, I., & Wigle, J. T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103207 · Cited by 17
Xu, X., Jiang, R., Chen, M., Dong, M., Liu, Q., Cheng, H., Zhou, K., Chen, L., Li, M., & Jiang, C. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000672 · Cited by 19
Zhao, L., Cheng, G., Choksi, K. B., Samanta, A., Girgis, M., Soder, R. P., Vincent, R. J., Wulser, M. J., DeRuyter, M. T., McEnulty, P. G., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315216 · Cited by 16
Li, X., Chu, G., Zhu, F., Zheng, Z., Wang, X., Zhang, G., & Wang, F. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111716 · Cited by 18
Zhang, W., Zheng, R., Bai, F., Sturdivant, K., Wang, N.-P., James, E. A., Bose, H. S., & Zhao, Z. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05222-7 · Cited by 16
“Release of TGFβ1 from activated macrophages elicits its signaling effect by binding cell surface receptors on the myofibroblasts, phosphorylates the members of intracellular receptor-regulated Smad proteins, and subsequently activates the transcription of target collagen genes [36, 37].”
BackgroundSingh, M. K., Ranbhise, J. S., Fu, M., Ju, S., Han, S., Yun, H. R., Choe, W., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110279 · Cited by 16
Gut-Heart Axis in Myocardial Repair: Mechanisms, Cross-Organ Networks, and Therapeutic Opportunities
Chen, H.-C., Tang, T. W.-H., Pasaribu, S. N. N., Wu, D.-C., Rey, F. E., & Hsieh, P. C. H. (2026) · Circulation Research · doi:10.1161/circresaha.125.326978 · Cited by 15
“27 Acetate, another SCFA, functions as an epigenetic regulator by serving as a substrate for acetyl-CoA (coenzyme A) via ACSS2 (acetyl-CoA synthetase 2).”
MED1 Deficiency in Macrophages Aggravates Isoproterenol-Induced Cardiac Fibrosis in Mice
Fatima, M., Gao, J., Han, T., Ding, Y., Zhang, Y., Wen, E., Jia, L., Wang, R., Wang, W., Zhao, S., et al. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.013 · Cited by 15
The Function and Therapeutic Potential of lncRNAs in Cardiac Fibrosis
Nie, X., Fan, J., & Wang, D. W. (2023) · Biology · doi:10.3390/biology12020154 · Cited by 16
“The TGF-β receptor is a dimeric receptor complex whose activation promotes the phosphorylation of Smad2/3 transcription factors through the canonical signaling pathway [78].”
BackgroundGarvin, A. M., & Katwa, L. C. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00224.2023 · Cited by 16
Wei, Z., Lu, Y., Qian, C., Li, J., & Li, X. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132486 · Cited by 15
Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signalling
Reilly-O’Donnell, B., Ferraro, E., Tikhomirov, R., Núñez-Toldrà, R., Shchendrygina, A., Patel, L., Wu, Y., Mitchell, A., Endo, A., Adorini, L., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1430772 · Cited by 19
Circular PVT1 promotes cardiac fibroblast activation interacting with miR-30a-5p and miR-125b-5p
Bibi, A., Madè, A., Greco, S., García-Manteiga, J. M., Tascini, A. S., Tastsoglou, S., Zaccagnini, G., Leszek, P., Gaetano, C., & Martelli, F. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07652-7 · Cited by 16
Transforming Growth Factor‐β Pathway: Biological Functions and Therapeutic Targets
Mekky, R. H., Fetoh, M. E. A., Faheem, S. A., Radwan, A., Fawzy, M. H., Mustafa, A. M., Said, M. A., Călina, D. C., Sharifi‐Rad, J., & Cho, W. C. S. (2025) · MedComm · doi:10.1002/mco2.70278 · Cited by 17
Embryonic programming of heart disease in response to obesity during pregnancy
Ahmed, A., & Delgado-Olguín, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.01.028 · Cited by 16
IMM-H007 improves heart function via reducing cardiac fibrosis
Ge, W., Zhang, W., Gao, R., Li, B., Zhu, H., & Wang, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172442 · Cited by 15
Zhang, M., Wang, H., Wang, X., Bie, M., Lü, K., & Xiao, H. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1827183 · Cited by 16
Zhang, M., Wang, H., Bie, M., Wang, X., Lü, K., & Xiao, H. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001066 · Cited by 16
Hippo signaling in cardiac fibroblasts during development, tissue repair, and fibrosis
Tsai, C.-R., & Martin, J. F. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.02.010 · Cited by 15
HuR-dependent expression of Wisp1 is necessary for TGF β -induced cardiac myofibroblast activity
Green, L. C., Slone, S., Anthony, S., Guarnieri, A., Parkins, S., Shearer, S. M., Nieman, M. L., Roy, S., Aubé, J., Wu, X., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.10.007 · Cited by 16
Self-citationmiR‑216a exacerbates TGF‑β‑induced myofibroblast transdifferentiation via PTEN/AKT signaling
Qu, C., Liu, X., Ye, T., Wang, L., Liu, S. H., Zhou, X., Wu, G., Lin, J., Shi, S., & Yang, B. Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10200 · Cited by 19
“A previous study reported that TGF‐β/Smad is the most common signaling pathway responsible for myofibroblast transdifferentiation, and that Smad3 is a critical and necessary mediator in this process (6).”
BackgroundTargeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
Amrute, J. M., Luo, X., Penna, V., Bredemeyer, A., Yamawaki, T., Heo, G. S., Shi, S., Koenig, A., Yang, S., Kadyrov, F., et al. (2022) · bioRxiv · doi:10.1101/2022.10.17.512579 · Cited by 14
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair
Zhang, M., Qin, Y., Zhou, T., Liu, M., Tang, T. A., Xia, N., Nie, S., Lv, B., Zhu, Z., Jiao, J., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.076321 · Cited by 20
Shi, S. Y., Luo, X., Yamawaki, T., Li, C.-M., Ason, B. L., & Furtado, M. B. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01517-z · Cited by 14
Beà, A., Valero, J. G., Irazoki, A., Lana, C., López‐Lluch, G., Portero‐Otín, M., Perez-Galan, P., Inserte, J., Ruiz‐Meana, M., Zorzano, A., et al. (2021) · FEBS Journal · doi:10.1111/febs.16283 · Cited by 14
The fate and role of the pericytes in myocardial diseases
Frangogiannis, N. G. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14204 · Cited by 16
Chen, W., Liu, L., Tang, M., Li, J., Yuan, W., Yin, D., Cao, Y., & Tian, J. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101162 · Cited by 14
“TGF-β is a solid and robust fibrogenic cytokine which plays a vital role in triggering myocardial fibrosis [16 – 18].”
BackgroundRath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01719-6 · Cited by 16
“The fibrotic microenvironment is highly dynamic, and studies have shown that chronic accumulation of ROS causes oxidative stress in fibrotic hearts and leads to cytokine production and DNA damage [6, 27, 28].”
BackgroundSecchia, S., Beilinson, V., Chen, X., Yang, Z. F., Wayman, J. A., Dhaliwal, J., Jurickova, I., Angerman, E., Denson, L. A., Miraldi, E. R., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115896 · Cited by 15
“…is implicated in cancer-associated fibroblast activation 33-37 ; SMAD3, a critical regulator of ECM remodeling downstream of transforming growth factor beta (TGF-β ) 38,39 ; and other basic-helix-loop-helix (bHLH) TFs (TCF3, USF1, and USF2), JUN TFs (JUN, JUNB, and JUND), TCF7L2, FLI1, and RUNX1.”
Kraus, L., Ma, L., Yang, Y., Nguyen, F., Hoy, R. C., Okuno, T., Khan, M., & Mohsin, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00494 · Cited by 14
“During cardiac injury myofibroblast transformations rely heavily on the transforming growth factor (TGF-β) signaling pathway (Khalil et al., 2017).”
BackgroundRepurposing mesalazine against cardiac fibrosis in vitro
Hoffmann, M., Kant, T. A., Emig, R., Rausch, J. S. E., Newe, M., Schubert, M., Künzel, K., Winter, L., Klapproth, E., Peyronnet, R., et al. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01998-9 · Cited by 14
“SMAD2/3 and ERK1/2 activation by TGFβ are central mechanisms of the fibrotic signaling cascade (Khalil et al. 2017; Khalil et al. 2017; Luo et al. 2017) and modulation of these pathways has been proposed to affect cardiac and non-cardiac fibrosis (Rosenbloom et al.”
BackgroundInfluentialChen, D., Tang, H., Jiang, H., Sun, L., Zhao, W., & Qian, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.835979 · Cited by 19
The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism
Mao, Y., Zhao, K., Li, P., & Sheng, Y. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04562-6 · Cited by 16
“At the cellular level, cardiac fibroblasts serve as the main sources of TGF-β, which exerts a broad range of direct autocrine effects on them, potentially contributing to the pathogenesis of cardiac fibrosis that predominantly occurs by stimulating myofibroblast transformation and promoting ECM synthesis via activated…”
BackgroundWang, H., Zhang, X., Liu, Y., Zhang, Y., Wang, Y., Peng, Y., & Ding, Y. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13802 · Cited by 14
Cavin-2 Promotes Fibroblast-to-Myofibroblast Trans-Differentiation and Aggravates Cardiac Fibrosis
Higuchi, Y., Ogata, T., Nakanishi, N., Nishi, M., Tsuji, Y., Tomita, S., Conway, S. J., & Matoba, S. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14571 · Cited by 14
Khurana, S., Waidha, K., Guleria, R., Sharda, S., & Bose, S. K. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107264 · Cited by 14
Macrophage–Fibroblast Crosstalk in Fibrosis: Key Regulator of Fibrosis Across Different Organs
Su, R., Song, L., Liu, Y., Zhang, C., Xie, L., & Han, Z. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl38864 · Cited by 14
Ikushima, E., Ishikane, S., Kishigami, T., Matsunaga, H., Igawa, K., Tomooka, K., Nishimura, Y., & Takahashi‐Yanaga, F. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114950 · Cited by 13
Wang, L.-F., Zha, H., Huang, J., & Shi, L. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5313 · Cited by 13
Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift?
Javed, S., & Halliday, B. P. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24 · Cited by 14
Zhu, N., Li, T., Bai, Y., Sun, J., Guo, J., Yuan, H., & Shan, Z. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09393-w · Cited by 14
“Cardiac fibroblasts were isolated from the atria of rats and cultured in Dulbecco’s Modified Eagle Medium (DMEM/ F12) supplemented with 10% fetal bovine serum (Med - ChemExpress, Monmouth, NJ), according to established protocols [ 21 ].”
MethodFerroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions
Wang, M., Mo, D.-G., Zhang, N., & Yu, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35219 · Cited by 15
“This leads to a higher production of lipid peroxidation products and ROS, which in turn promotes ferroptosis [103,129,150,151].”
BackgroundDing, Q., Yang, W., Xue, G., Liu, H., Cai, Y., Que, J., Jin, X., Luo, M., Pang, F., Yang, Y., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03385-6 · Cited by 14
“For the convenience of observation, we only show the top 50 CCC pathways according to the correlation score between receptors and TFs in the Sankey plot, such as SMAD2, SMAD3, and SMAD4, which have been validated to be involved in skin fibrosis [74].”
MethodCardiac Fibroblasts: Helping or Hurting
Shameem, M., Olson, S. L., de Velasco, E. M. F., Kumar, A., & Singh, B. N. (2025) · Genes · doi:10.3390/genes16040381 · Cited by 16
“Gene knock-out mice studies showed that the deletion of TGF-β receptors or Smad2/3 in CFs led to reduced fibrosis and hypertrophy in response to pathological stimuli [80,81].”
Aguado‐Alvaro, L. P., Garitano, N., Esser‐Skala, W., Sayers, J. R., del Valle, C., Alameda, D., Mendieta-Esteban, J., Calleja-Cervantes, M. E., Goñi‐Salaverri, A., Zazpe, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66597-9 · Cited by 15
Dimitrijević, Z., Šalinger-Martinović, S., Nikolic, V. N., & Cvetković, T. (2019) · Diagnostics · doi:10.3390/diagnostics9040202 · Cited by 14
“TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins and collagen type I, which, in turn, cause eccentric hypertrophy and fibrosis [57].”
BackgroundLiao, R., Xie, B., Cui, J., Qi, Z., Xue, S., & Wang, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1972194 · Cited by 18
“TβRI binds with SMAD4 and enters together with TβRI into cell nucleus to promote transcription of fibrosisrelated genes [3,5].”
BackgroundRurik, J. G., & Epstein, J. A. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0171 · Cited by 13
Ye, B., Hu, Y., ZHANG, M., & Huang, H. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0047 · Cited by 21
Hu, H., Huang, J., Zhang, S., Zhang, B., Li, W., & Sun, K. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23411 · Cited by 14
Wu, Y., Chen, C., Bi, F., Wu, C., Li, J., Hou, Y.-M., Jing, Z.-H., Pan, Q.-M., Cao, M., Lv, L., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174892 · Cited by 13
Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice
Deng, J., Wei, R.-Q., Zhang, W., Shi, C.-Y., Yang, R., Jin, M., & Piao, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-62900-8 · Cited by 13
“Activation of TGF-β1 induces the phosphorylation of Smad2/3, which forms the Smad complex and interacts with transcription factors, such as α-SMA, to promote gene expression 48–50 .”
Jiang, Z., Yang, F., Cao, H., Xing, C., Wang, H., Chen, J., Hu, G., Gao, X., Li, G., Guo, X., et al. (2024) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2024.106180 · Cited by 12
Quercetin Alleviates Cardiac Fibrosis via Regulating the SIRT3 Signaling Pathway
Lin, D., Jiang, Y., Wu, C., Zhang, H., Li, Y.-Z., & Yaosheng, W. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07658-x · Cited by 15
Sun, L., Zhang, H., Jiang, H., Li, W., Li, M., Yang, X.-Y., Cai, Y., Xue, K.-K., Gou, Y., Liu, X., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01488-9 · Cited by 13
Cell type specificity of Hippo-YAP signaling in cardiac development and disease
Guan, J., & Re, D. P. D. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.08.003 · Cited by 13
Merce, A.-G., Nisulescu, D. D., Hermenean, A. O., Burciu, O. M., Munteanu, I.-R., Merce, A.-P., Brie, D. M., & Mornoş, C. (2026) · Metabolites · doi:10.3390/metabo16010059 · Cited by 12
“In addition, progressive fibrosis in diabetic and hypertensive cardiomyopathy is largely facilitated by TGF-β 1–Smad3 signaling [53].”
Wang, C.-J., Li, B., Tan, Y., Zhang, G., Cheng, G., & Ren, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117205 · Cited by 12
Ma, Z., Zhang, K., Wang, Y., Wang, W., Yu, Y., Liang, X., Zhang, Y., & Li, G. (2020) · Medical Science Monitor · doi:10.12659/msm.918883 · Cited by 12
CARD9 Regulation and its Role in Cardiovascular Diseases
Zhang, H., Wang, Y., Men, H., Zhou, W., Zhou, S., Liu, Q., & Cai, L. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65979 · Cited by 14
Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis
Chattopadhyaya, S., Nagalingam, R. S., Ledingham, D. A., Moffatt, T. L., Al‐Hattab, D. S., Narhan, P., Stecy, M. T., O’Hara, K. A., & Czubryt, M. P. (2022) · Cells · doi:10.3390/cells11091471 · Cited by 12
Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids
Wintzinger, M., Panta, M., Miz, K., Prabakaran, A. D., Durumutla, H. B., Sargent, M. A., Peek, C. B., Bass, J. T., Molkentin, J. D., & Quattrocelli, M. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101528 · Cited by 13
“Echocardiography was performed in mice under 2% isoflurane inhalation anesthesia and the measurements were performed using a Vevo 2100 instrument with 18e38 MHz transducer (VisualSonics) as previously described [54,56,57], using M and B-mode recordings for fractional shortening and stroke volume quantitation.”
MethodSelf-citation
Metadata
- Authors
- Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., Karch, J., & Molkentin, J. D.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-09-11
- Volume
- 127
- Issue
- 10
- Pages
- 3770-3783
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5617658
- OpenAlex
- W2750808153
- Cited by
- 905
- References
- 64
- Citations by year
- 2026: 92 · 2025: 102 · 2024: 128 · 2023: 121 · 2022: 144 · 2021: 110 · 2020: 84 · 2019: 85 · 2018: 34 · 2017: 2
- FWCI
- 43.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Language arts journal of Michigan (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (158486, 148429)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL105924)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, TGF-beta signaling, Smad2, Smad3, cardiac fibroblasts, myofibroblasts, TGF-beta receptor, pressure overload, cardiac hypertrophy, extracellular matrix remodeling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Animals, Fibrosis, Heart Diseases, Male, Mice, Transgenic, Myocardium, Organ Specificity, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Myocytes, Cardiac, Mice, Smad2 Protein, Smad3 Protein, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.